Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Trial Details

NCT ID

NCT05354375

Phase

PHASE1

Sponsor

The Affiliated Hospital of Xuzhou Medical University

Status

RECRUITING

Cancer Type

Prostate Cancer

Interventions

• CAR-T cell immunotherapy

Locations (sample)

• Xuzhou, Jiangsu, China|34.20442,117.28386

Key Eligibility Criteria

• Male patients aged from 18 to 75 years old;
• The patients' ECOG score ≤ 2;
• Prostate cancer patients in castration resistance stage (with or without distant metastasis):
• Previous new endocrine therapy is ineffective;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.